An Imaging Study in Patients With Thyroid Cancer or Head and Neck Cancer With Pertechnetate Made in a Cyclotron (C-PERT)
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Doctors at the Cross Cancer Institute have developed a new method of producing 99mTc
Pertechnetate in a cyclotron unit. A study done at the Cross Cancer Institute in 2011 with
ten patients using this imaging agent showed that it was safe and produced images with the
same pattern as generator produced Pertechnetate. This study is now being done in larger
numbers of patients to again show that the imaging pattern of both agents is the same, and to
again demonstrate its safety.